30 results on '"Thomas Strub"'
Search Results
2. LKB1‐SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition
- Author
-
Sarah Proteau, Imène Krossa, Chrystel Husser, Maxime Guéguinou, Federica Sella, Karine Bille, Marie Irondelle, Mélanie Dalmasso, Thibault Barouillet, Yann Cheli, Céline Pisibon, Nicole Arrighi, Sacha Nahon‐Estève, Arnaud Martel, Lauris Gastaud, Sandra Lassalle, Olivier Mignen, Patrick Brest, Nathalie M Mazure, Frédéric Bost, Stéphanie Baillif, Solange Landreville, Simon Turcotte, Dan Hasson, Saul Carcamo, Christophe Vandier, Emily Bernstein, Laurent Yvan‐Charvet, Mitchell P Levesque, Robert Ballotti, Corine Bertolotto, and Thomas Strub
- Subjects
calcium ,LKB1 ,SIK2 ,SLC8A1 ,uveal melanoma ,Medicine (General) ,R5-920 ,Genetics ,QH426-470 - Abstract
Abstract Metastatic uveal melanomas are highly resistant to all existing treatments. To address this critical issue, we performed a kinome‐wide CRISPR‐Cas9 knockout screen, which revealed the LKB1‐SIK2 module in restraining uveal melanoma tumorigenesis. Functionally, LKB1 loss enhances proliferation and survival through SIK2 inhibition and upregulation of the sodium/calcium (Na+/Ca2+) exchanger SLC8A1. This signaling cascade promotes increased levels of intracellular calcium and mitochondrial reactive oxygen species, two hallmarks of cancer. We further demonstrate that combination of an SLC8A1 inhibitor and a mitochondria‐targeted antioxidant promotes enhanced cell death efficacy in LKB1‐ and SIK2‐negative uveal melanoma cells compared to control cells. Our study also identified an LKB1‐loss gene signature for the survival prognostic of patients with uveal melanoma that may be also predictive of response to the therapy combination. Our data thus identify not only metabolic vulnerabilities but also new prognostic markers, thereby providing a therapeutic strategy for particular subtypes of metastatic uveal melanoma.
- Published
- 2023
- Full Text
- View/download PDF
3. ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity
- Author
-
Yann Cheli, Meri K. Tulic, Najla El Hachem, Nicolas Nottet, Arnaud Jacquel, Maeva Gesson, Thomas Strub, Karine Bille, Alexandra Picard-Gauci, Henri Montaudié, Guillaume E. Beranger, Thierry Passeron, Pierre Close, Corine Bertolotto, and Robert Ballotti
- Subjects
Melanoma ,ITGBL1 ,MITF ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Resistances to immunotherapies remains a major hurdle towards a cure for melanoma in numerous patients. An increase in the mesenchymal phenotype and a loss of differentiation have been clearly associated with resistance to targeted therapies. Similar phenotypes have been more recently also linked to resistance to immune checkpoint therapies. We demonstrated here that the loss of MIcrophthalmia associated Transcription Factor (MITF), a pivotal player in melanocyte differentiation, favors the escape of melanoma cells from the immune system. We identified Integrin beta-like protein 1 (ITGBL1), a secreted protein, upregulated in anti-PD1 resistant patients and in MITFlow melanoma cells, as the key immunomodulator. ITGBL1 inhibited immune cell cytotoxicity against melanoma cells by inhibiting NK cells cytotoxicity and counteracting beneficial effects of anti-PD1 treatment, both in vitro and in vivo. Mechanistically, MITF inhibited RUNX2, an activator of ITGBL1 transcription. Interestingly, VitaminD3, an inhibitor of RUNX2, improved melanoma cells to death by immune cells. In conclusion, our data suggest that inhibition of ITGBL1 might improve melanoma response to immunotherapies.
- Published
- 2021
- Full Text
- View/download PDF
4. Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma?
- Author
-
Imène Krossa, Thomas Strub, Andrew E. Aplin, Robert Ballotti, and Corine Bertolotto
- Subjects
epigenetics ,cancers ,melanoma ,therapies ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Epigenetic regulations, that comprise histone modifications and DNA methylation, are essential to processes as diverse as development and cancer. Among the histone post-translational modifications, lysine methylation represents one of the most important dynamic marks. Here, we focused on methyltransferases of the nuclear binding SET domain 1 (NSD) family, that catalyze the mono- and di-methylation of histone H3 lysine 36. We review the loss of function mutations of NSD1 in humans that are the main cause of SOTOS syndrome, a disease associated with an increased risk of developing cancer. We then report the role of NSD1 in triggering tumor suppressive or promoter functions according to the tissue context and we discuss the role of NSD1 in melanoma. Finally, we examine the ongoing efforts to target NSD1 signaling in cancers.
- Published
- 2022
- Full Text
- View/download PDF
5. MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance
- Author
-
Maria Chiara Gelmi, Laurien E. Houtzagers, Thomas Strub, Imène Krossa, and Martine J. Jager
- Subjects
eye ,oncology ,melanoma ,MITF ,melanocyte ,cutaneous melanoma ,Biology (General) ,QH301-705.5 ,Chemistry ,QD1-999 - Abstract
Microphthalmia-associated transcription factor (MITF) is an important regulator of melanogenesis and melanocyte development. Although it has been studied extensively in cutaneous melanoma, the role of MITF in uveal melanoma (UM) has not been explored in much detail. We review the literature about the role of MITF in normal melanocytes, in cutaneous melanoma, and in UM. In normal melanocytes, MITF regulates melanocyte development, melanin synthesis, and melanocyte survival. The expression profile and the behaviour of MITF-expressing cells suggest that MITF promotes local proliferation and inhibits invasion, inflammation, and epithelial-to-mesenchymal (EMT) transition. Loss of MITF expression leads to increased invasion and inflammation and is more prevalent in malignant cells. Cutaneous melanoma cells switch between MITF-high and MITF-low states in different phases of tumour development. In UM, MITF loss is associated with loss of BAP1 protein expression, which is a marker of poor prognosis. These data indicate a dual role for MITF in benign and malignant melanocytic cells.
- Published
- 2022
- Full Text
- View/download PDF
6. SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling
- Author
-
Thomas Strub, Flavia G. Ghiraldini, Saul Carcamo, Man Li, Aleksandra Wroblewska, Rajendra Singh, Matthew S. Goldberg, Dan Hasson, Zichen Wang, Stuart J. Gallagher, Peter Hersey, Avi Ma’ayan, Georgina V. Long, Richard A. Scolyer, Brian Brown, Bin Zheng, and Emily Bernstein
- Subjects
Science - Abstract
The epigenetic mechanisms of melanoma drug resistance are poorly understood. Here, the authors develop a CRISPR-Cas9 screen targeting epigenetic regulators and discover that SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling.
- Published
- 2018
- Full Text
- View/download PDF
7. Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity
- Author
-
Yann Cheli, Meri K. Tulic, Najla El Hachem, Nicolas Nottet, Arnaud Jacquel, Maeva Gesson, Thomas Strub, Karine Bille, Alexandra Picard-Gauci, Henri Montaudié, Guillaume E. Beranger, Thierry Passeron, Pierre Close, Corine Bertolotto, and Robert Ballotti
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
An amendment to this paper has been published and can be accessed via the original article.
- Published
- 2021
- Full Text
- View/download PDF
8. Chromatin-Remodelling Complex NURF Is Essential for Differentiation of Adult Melanocyte Stem Cells.
- Author
-
Dana Koludrovic, Patrick Laurette, Thomas Strub, Céline Keime, Madeleine Le Coz, Sebastien Coassolo, Gabrielle Mengus, Lionel Larue, and Irwin Davidson
- Subjects
Genetics ,QH426-470 - Abstract
MIcrophthalmia-associated Transcription Factor (MITF) regulates melanocyte and melanoma physiology. We show that MITF associates the NURF chromatin-remodelling factor in melanoma cells. ShRNA-mediated silencing of the NURF subunit BPTF revealed its essential role in several melanoma cell lines and in untransformed melanocytes in vitro. Comparative RNA-seq shows that MITF and BPTF co-regulate overlapping gene expression programs in cell lines in vitro. Somatic and specific inactivation of Bptf in developing murine melanoblasts in vivo shows that Bptf regulates their proliferation, migration and morphology. Once born, Bptf-mutant mice display premature greying where the second post-natal coat is white. This second coat is normally pigmented by differentiated melanocytes derived from the adult melanocyte stem cell (MSC) population that is stimulated to proliferate and differentiate at anagen. An MSC population is established and maintained throughout the life of the Bptf-mutant mice, but these MSCs are abnormal and at anagen, give rise to reduced numbers of transient amplifying cells (TACs) that do not express melanocyte markers and fail to differentiate into mature melanin producing melanocytes. MSCs display a transcriptionally repressed chromatin state and Bptf is essential for reactivation of the melanocyte gene expression program at anagen, the subsequent normal proliferation of TACs and their differentiation into mature melanocytes.
- Published
- 2015
- Full Text
- View/download PDF
9. Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells
- Author
-
Patrick Laurette, Thomas Strub, Dana Koludrovic, Céline Keime, Stéphanie Le Gras, Hannah Seberg, Eric Van Otterloo, Hana Imrichova, Robert Siddaway, Stein Aerts, Robert A Cornell, Gabrielle Mengus, and Irwin Davidson
- Subjects
chromatin remodelling ,SOX10 ,CHD7 ,YY1 ,TFAP2A ,enhancer ,Medicine ,Science ,Biology (General) ,QH301-705.5 - Abstract
Microphthalmia-associated transcription factor (MITF) is the master regulator of the melanocyte lineage. To understand how MITF regulates transcription, we used tandem affinity purification and mass spectrometry to define a comprehensive MITF interactome identifying novel cofactors involved in transcription, DNA replication and repair, and chromatin organisation. We show that MITF interacts with a PBAF chromatin remodelling complex comprising BRG1 and CHD7. BRG1 is essential for melanoma cell proliferation in vitro and for normal melanocyte development in vivo. MITF and SOX10 actively recruit BRG1 to a set of MITF-associated regulatory elements (MAREs) at active enhancers. Combinations of MITF, SOX10, TFAP2A, and YY1 bind between two BRG1-occupied nucleosomes thus defining both a signature of transcription factors essential for the melanocyte lineage and a specific chromatin organisation of the regulatory elements they occupy. BRG1 also regulates the dynamics of MITF genomic occupancy. MITF-BRG1 interplay thus plays an essential role in transcription regulation in melanoma.
- Published
- 2015
- Full Text
- View/download PDF
10. Asynchronous OpenCL/MPI Numerical Simulations of Conservation Laws.
- Author
-
Philippe Helluy, Thomas Strub, Michel Massaro, and Malcolm Roberts
- Published
- 2016
- Full Text
- View/download PDF
11. Recent advances in understanding the role of HES6 in cancers
- Author
-
Imène Krossa, Thomas Strub, Arnaud Martel, Sacha Nahon-Esteve, Sandra Lassalle, Paul Hofman, Stéphanie Baillif, Robert Ballotti, and Corine Bertolotto
- Subjects
Repressor Proteins ,Uveal Neoplasms ,Pregnancy ,Basic Helix-Loop-Helix Transcription Factors ,Medicine (miscellaneous) ,Humans ,Female ,Pharmacology, Toxicology and Pharmaceutics (miscellaneous) ,Melanoma ,Signal Transduction - Abstract
The NOTCH signaling system regulates a variety of cellular processes during embryonic development and homeostasis maintenance in different tissues and contexts. Hence, dysregulation of NOTCH signaling is associated with a plethora of human cancers, and there have been multiple efforts to target key components of this pathway. In this review, we briefly highlight the latest research advances in understanding HES6, a poorly studied component of the NOTCH pathway. We summarize the role of HES6 in cancers with a focus on uveal melanoma. Finally, we discuss the ongoing efforts to target the NOTCH-HES6 axis in cancers.
- Published
- 2022
12. Asynchronous OpenCL/MPI numerical simulations of conservation laws.
- Author
-
Philippe Helluy, Thomas Strub, Michel Massaro, and Malcolm Roberts
- Published
- 2015
- Full Text
- View/download PDF
13. ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity
- Author
-
Corine Bertolotto, Thomas Strub, Henri Montaudié, Pierre Close, Thierry Passeron, Karine Bille, Arnaud Jacquel, Najla El Hachem, Robert Ballotti, Maeva Gesson, Meri K. Tulic, Guillaume E. Beranger, Alexandra Picard-Gauci, Yann Cheli, Nicolas Nottet, Centre méditerranéen de médecine moléculaire (C3M), Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Université Côte d'Azur (UCA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Liège, Service de Dermatologie [Nice], Hôpital Archet 2 [Nice] (CHU), Université Nice Sophia Antipolis (1965 - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Côte d'Azur (UCA), and BERTOLOTTO-BALLOTTI, BERTOLOTTO-BALLOTTI
- Subjects
0301 basic medicine ,Cytotoxicity, Immunologic ,Cancer Research ,Carcinogenesis ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,Biology ,lcsh:RC254-282 ,03 medical and health sciences ,0302 clinical medicine ,Immune system ,[SDV.CAN] Life Sciences [q-bio]/Cancer ,Melanocyte differentiation ,Downregulation and upregulation ,Cell Line, Tumor ,medicine ,Animals ,Immunologic Factors ,Cytotoxicity ,Letter to the Editor ,Melanoma ,ITGBL1 ,Cell Proliferation ,Microphthalmia-Associated Transcription Factor ,MITF ,Integrin beta1 ,Correction ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Microphthalmia-associated transcription factor ,medicine.disease ,Immune checkpoint ,3. Good health ,RUNX2 ,Killer Cells, Natural ,Mice, Inbred C57BL ,030104 developmental biology ,Oncology ,030220 oncology & carcinogenesis ,Cancer research ,Molecular Medicine - Abstract
Erratum inCorrection to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity.Cheli Y, Tulic MK, El Hachem N, Nottet N, Jacquel A, Gesson M, Strub T, Bille K, Picard-Gauci A, Montaudié H, Beranger GE, Passeron T, Close P, Bertolotto C, Ballotti R.Mol Cancer. 2021 Jan 27;20(1):21. doi: 10.1186/s12943-021-01319-5.PMID: 33504341 Free PMC article. No abstract available.; International audience; Resistances to immunotherapies remains a major hurdle towards a cure for melanoma in numerous patients. An increase in the mesenchymal phenotype and a loss of differentiation have been clearly associated with resistance to targeted therapies. Similar phenotypes have been more recently also linked to resistance to immune checkpoint therapies. We demonstrated here that the loss of MIcrophthalmia associated Transcription Factor (MITF), a pivotal player in melanocyte differentiation, favors the escape of melanoma cells from the immune system. We identified Integrin beta-like protein 1 (ITGBL1), a secreted protein, upregulated in anti-PD1 resistant patients and in MITFlow melanoma cells, as the key immunomodulator. ITGBL1 inhibited immune cell cytotoxicity against melanoma cells by inhibiting NK cells cytotoxicity and counteracting beneficial effects of anti-PD1 treatment, both in vitro and in vivo. Mechanistically, MITF inhibited RUNX2, an activator of ITGBL1 transcription. Interestingly, VitaminD3, an inhibitor of RUNX2, improved melanoma cells to death by immune cells. In conclusion, our data suggest that inhibition of ITGBL1 might improve melanoma response to immunotherapies.
- Published
- 2021
14. Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease
- Author
-
Stéphanie Baillif, Marie Irondelle, Arnaud Martel, Chrystel Husser, Nicolas Nottet, Sacha Nahon-Esteve, Irwin Davidson, Pascal Barbry, Thomas Strub, Kevin Lebrigand, Celia Maschi, Yann Cheli, Sandra Lassalle, Corine Bertolotto, Paul Hofman, Florence Pedeutour, Mélanie Dalmasso, Giovanni Gambi, Virginie Magnone, Guillaume E. Beranger, Robert Ballotti, Karine Bille, Jean-Pierre Caujolle, Charlotte Pandiani, Centre Hospitalier Universitaire de Nice (CHU Nice), Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut de pharmacologie moléculaire et cellulaire (IPMC), Université Nice Sophia Antipolis (... - 2019) (UNS), and COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
0301 basic medicine ,Uveal Neoplasms ,[SDV]Life Sciences [q-bio] ,Cell ,Biology ,Article ,Metastasis ,Transcriptome ,03 medical and health sciences ,0302 clinical medicine ,Cell Line, Tumor ,medicine ,Basic Helix-Loop-Helix Transcription Factors ,Humans ,Neoplasm Metastasis ,Molecular Biology ,Gene ,Transcription factor ,Melanoma ,ComputingMilieux_MISCELLANEOUS ,Sequence Analysis, RNA ,RNA ,Cell Biology ,medicine.disease ,Prognosis ,Primary tumor ,3. Good health ,Repressor Proteins ,030104 developmental biology ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Cancer research ,Single-Cell Analysis - Abstract
Intratumor heterogeneity has been recognized in numerous cancers as a major source of metastatic dissemination. In uveal melanomas, the existence and identity of specific subpopulations, their biological function and their contribution to metastasis remain unknown. Here, in multiscale analyses using single-cell RNA sequencing of six different primary uveal melanomas, we uncover an intratumoral heterogeneity at the genomic and transcriptomic level. We identify distinct transcriptional cell states and diverse tumor-associated populations in a subset of the samples. We also decipher a gene regulatory network underlying an invasive and poor prognosis state driven in part by the transcription factor HES6. HES6 heterogenous expression has been validated by RNAscope assays within primary human uveal melanomas, which further unveils the existence of these cells conveying a dismal prognosis in tumors diagnosed with a favorable outcome using bulk analyses. Depletion of HES6 impairs proliferation, migration and metastatic dissemination in vitro and in vivo using the chick chorioallantoic membrane assay, demonstrating the essential role of HES6 in uveal melanomas. Thus, single-cell analysis offers an unprecedented view of primary uveal melanoma heterogeneity, identifies bona fide biomarkers for metastatic cells in the primary tumor, and reveals targetable modules driving growth and metastasis formation. Significantly, our findings demonstrate that HES6 is a valid target to stop uveal melanoma progression.
- Published
- 2020
15. Translation of single-cell transcriptomic analysis of uveal melanomas to clinical oncology
- Author
-
Arnaud Martel, Stéphanie Baillif, Thomas Strub, Corine Bertolotto, Sacha Nahon-Esteve, and Robert Ballotti
- Subjects
Uveal Neoplasms ,0301 basic medicine ,Tumour heterogeneity ,Genomics ,Computational biology ,Disease ,Medical Oncology ,Metastasis ,03 medical and health sciences ,0302 clinical medicine ,Single-cell analysis ,Tumor Microenvironment ,Humans ,Medicine ,Melanoma ,Ecosystem ,business.industry ,Cancer ,medicine.disease ,Sensory Systems ,Ophthalmology ,030104 developmental biology ,Cancer cell ,030221 ophthalmology & optometry ,Transcriptome ,business - Abstract
Uveal melanoma (UM) is an aggressive and deadly neoplasm. In recent decades, great efforts have been made to obtain a more comprehensive understanding of genetics, genomics and molecular changes in UM, enabling the identification of key cellular processes and signalling pathways. Still, there is no effective treatment for the metastatic disease. Intratumoural heterogeneity (ITH) is thought to be one of the leading determinants of metastasis, therapeutic resistance and recurrence. Crucially, tumours are complex ecosystems, where cancer cells, and diverse cell types from their microenvironment engage in dynamic spatiotemporal crosstalk that allows cancer progression, adaptation and evolution. This highlights the urgent need to gain insight into ITH in UM and its intersection with the microenvironment to overcome treatment failure. Here we provide an overview of the studies and technologies to study ITH in human UMs and tumour micro-environmental composition. We discuss how to incorporate ITH into clinical consideration for the purpose of advocating for new clinical management. We focus on the application of single-cell transcriptomic analysis and propose that understanding the driving forces and functional consequences of the observed tumour heterogeneity holds promise for changing the treatment paradigm of metastatic UMs, surmounting resistance and improving patient prognosis.
- Published
- 2021
16. Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity
- Author
-
Alexandra Picard-Gauci, Maeva Gesson, Meri K. Tulic, Corine Bertolotto, Nicolas Nottet, Pierre Close, Guillaume E. Beranger, Arnaud Jacquel, Henri Montaudié, Yann Cheli, Robert Ballotti, Thomas Strub, Najla El Hachem, Thierry Passeron, and Karine Bille
- Subjects
Cancer Research ,Oncology ,Melanoma ,medicine ,Cancer research ,Molecular Medicine ,Biology ,medicine.disease ,Cytotoxicity ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,lcsh:RC254-282 - Abstract
An amendment to this paper has been published and can be accessed via the original article.
- Published
- 2021
17. Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression
- Author
-
Jean-François Ottavi, Brigitte Bressac-de Paillerets, Karine Bille, Gian Marco De Donatis, Guillaume Bossis, Thomas Strub, Mickaël Ohanna, Stéphane Rocchi, Jean-Philippe Lacour, Véronique Hofman, Irwin Davidson, Sandrine Marchetti, Yann Cheli, Marie-Christine Birling, Paul Hofman, Thomas Luc, Jean-Christophe Marine, Frederic Luciano, Fanélie-Marie Jouenne, Marina Boncompagni, Corine Bertolotto, Flavie Luciani, Marie-Françoise Avril, Caroline Bonet, Justine Leclerc, N. Poulalhon, Robert Ballotti, Centre méditerranéen de médecine moléculaire (C3M), Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Université Côte d'Azur (UCA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Régulations cellulaires et oncogenèse (RCO), Institut Curie [Paris]-Centre National de la Recherche Scientifique (CNRS), Réponses cellulaires au microenvironnement et cancer, Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Gustave Roussy (IGR), Biologie et pathologies des cellules mélanocytaires : de la pigmentation cutanée aux mélanomes, COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-IFR50-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Côte d'Azur (UCA), Institut de Recherche sur le Cancer et le Vieillissement (IRCAN), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Côte d'Azur (UCA), Institut de Génétique Moléculaire de Montpellier (IGMM), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), AxesSim, Physiopathologie de la survie et de la mort cellulaire et infection virale, French National Infrastructure for Mouse Phenogenomics (PHENOMIN), Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Département de Dermatologie [CH Lyon-Sud, Pierre-Bénite], Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL), ERI-21/EA 4319, Laboratoire de Pathologie Clinique et Expérimentale et CRB INSERM, Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Louis Pasteur [Chartres]-Université de Nice Sophia-Antipolis (UNSA), Service de Dermatologie [Nice], Hôpital Archet 2 [Nice] (CHU), Institut de génétique et biologie moléculaire et cellulaire (IGBMC), Université Louis Pasteur - Strasbourg I-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Immunologie intégrative des tumeurs (UMR 1186), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), This work was funded by la Société Française de Dermatologie, Melanoma Research Alliance (MRA Team Science Award #269626), ANR-13-BSV1-0025-01 to RB, Fondation pour la Recherche Médicale, La Ville de Nice, Cancéropôle PACA to CB, INCa grant 2013-1-MELA-05 to BBdP, Grant Fondation Gustave Roussy 2009, No. PRI-2010-18 to BBdP, Grant 2011 ITMO-Plan Cancer to BBdP, ICGC No. 201102 to BBdP., ANR-13-BSV1-0025,MITF-SUMOcode,Role de la SUMOylation de MITF (Microphthalmia associated Transcription Factor) dans la pigmentation cutanée, et le développement des nævus.(2013), Université Nice Sophia Antipolis (1965 - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Côte d'Azur (UCA), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), BERTOLOTTO-BALLOTTI, BERTOLOTTO-BALLOTTI, and Blanc 2013 - Role de la SUMOylation de MITF (Microphthalmia associated Transcription Factor) dans la pigmentation cutanée, et le développement des nævus. - - MITF-SUMOcode2013 - ANR-13-BSV1-0025 - Blanc 2013 - VALID
- Subjects
0301 basic medicine ,Senescence ,Adult ,Proto-Oncogene Proteins B-raf ,Cancer Research ,Skin Neoplasms ,Primary Cell Culture ,Endogeny ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,Proximity ligation assay ,Biology ,Melanin ,03 medical and health sciences ,Mice ,Germline mutation ,[SDV.CAN] Life Sciences [q-bio]/Cancer ,Cell Line, Tumor ,medicine ,Nevus ,Animals ,Humans ,Melanoma ,Cellular Senescence ,Germ-Line Mutation ,Aged ,Microphthalmia-Associated Transcription Factor ,integumentary system ,PTEN Phosphohydrolase ,Sumoylation ,Middle Aged ,medicine.disease ,Microphthalmia-associated transcription factor ,3. Good health ,body regions ,Disease Models, Animal ,030104 developmental biology ,Oncology ,Cancer research ,Melanocytes ,Transcriptome - Abstract
International audience; BACKGROUND:MITF encodes an oncogenic lineage-specific transcription factor in which a germline mutation ( MITFE318K ) was identified in human patients predisposed to both nevus formation and, among other tumor types, melanoma. The molecular mechanisms underlying the oncogenic activity of MITF E318K remained uncharacterized.METHODS:Here, we compared the SUMOylation status of endogenous MITF by proximity ligation assay in melanocytes isolated from wild-type (n = 3) or E318K (n = 4) MITF donors. We also used a newly generated Mitf E318K knock-in (KI) mouse model to assess the role of Mitf E318K (n = 7 to 13 mice per group) in tumor development in vivo and performed transcriptomic analysis of the tumors to identify the molecular mechanisms. Finally, using immortalized or normal melanocytes (wild-type or E318K MITF, n = 2 per group), we assessed the role of MITF E318K on the induction of senescence mediated by BRAF V600E . All statistical tests were two-sided.RESULTS:We demonstrated a decrease in endogenous MITF SUMOylation in melanocytes from MITF E318K patients (mean of cells with hypoSUMOylated MITF, MITF E318K vs MITF WT , 94% vs 44%, difference = 50%, 95% CI = 21.8% to 67.2%, P = .004). The Mitf E318K mice were slightly hypopigmented (mean melanin content Mitf WT vs Mitf E318K/+ , 0.54 arbitrary units [AU] vs 0.36 AU, difference = -0.18, 95% CI = -0.36 to -0.007, P = .04). We provided genetic evidence that Mitf E318K enhances BRaf V600E -induced nevus formation in vivo (mean nevus number for Mitf E318K , BRaf V600E vs Mitf WT , BRaf V600E , 68 vs 44, difference = 24, 95% CI = 9.1 to 38.9, P = .006). Importantly, although Mitf E318K was not sufficient to cooperate with BRaf V600E alone in promoting metastatic melanoma, it accelerated tumor formation on a BRaf V600E , Pten-deficient background (median survival, Mitf E318K/+ = 42 days, 95% CI = 31 to 46 vs Mitf WT = 51 days, 95% CI = 50 to 55, P
- Published
- 2017
18. Multi-GPU numerical simulation of electromagnetic waves*
- Author
-
Philippe Helluy, Thomas Strub, TOkamaks and NUmerical Simulations (TONUS), Institut de Recherche Mathématique Avancée (IRMA), Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS)-Inria Nancy - Grand Est, Institut National de Recherche en Informatique et en Automatique (Inria)-Institut National de Recherche en Informatique et en Automatique (Inria), AxesSim, This work is part of the project GREAT (Galerkin Resolution for Electromagnetic Applications in the Time domain) supported by DGA/DS/MRIS through a dual innovation project RAPID., and Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Inria Nancy - Grand Est
- Subjects
Maxwell ,Computer science ,Computation ,GPU ,02 engineering and technology ,Parallel computing ,01 natural sciences ,Electromagnetic radiation ,symbols.namesake ,Discontinuous Galerkin method ,Discontinuous Galerkin ,0202 electrical engineering, electronic engineering, information engineering ,QA1-939 ,[MATH.MATH-AP]Mathematics [math]/Analysis of PDEs [math.AP] ,0101 mathematics ,Galerkin method ,Multi-core processor ,T57-57.97 ,Applied mathematics. Quantitative methods ,Computer simulation ,OpenCL ,020206 networking & telecommunications ,Domain decomposition methods ,010101 applied mathematics ,Computer Science::Performance ,Maxwell's equations ,symbols ,MPI ,Mathematics - Abstract
International audience; In this paper we present three-dimensional numerical simulations of electromagnetic waves. The Maxwell equations are solved by the Discontinuous Galerkin (DG) method. For achieving high performance, we exploit two levels of parallelism. The coarse grain parallelism is managed through MPI and a classical domain decomposition. The fine grain parallelism is managed with OpenCL in order to optimize the local computations on multicore processors or GPU's. We present several numerical experiments and performance comparisons.; Dans cet article, nous présentons des simulations numériques tridimensionnelles d’ondes électromagnétiques. Les équations de Maxwell sont résolues par la méthode de Galerkin Discontinue (GD). Pour accélérer les calculs, nous exploitons deux niveaux de parallélisme. Le large grain est basé sur MPI. Le parallélisme à grain fin repose sur OpenCL afin d’exploiter les processeurs massivement multicoeur (GPU ou CPU) récents. Nous présentons plusieurs expériences numériques et des tests de performance.
- Published
- 2014
19. Corrigendum: A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma
- Author
-
Olivier Caron, Etienne Rouleau, Hamida Mohamdi, F. Boitier, Jean-Luc Perrot, Eve Maubec, Arnaud de la Fouchardière, Stéphane Richard, Pierre Vabres, Luc Thomas, Rosette Lidereau, Simon Saule, Diana Zelenika, Pilar Galan, Tanguy Martin-Denavit, Lorenza Pastorino, N. Poulalhon, Jérôme Couturier, Bruno Labeille, Eve Corda, Caroline Robert, Philippe Dessen, Marie-Françoise Avril, Bernard Escudier, Christian Ingvar, Sandy Giuliano, Celia Badenas, Robert Ballotti, Benoit d’Hayer, Gilbert M. Lenoir, Betty Gardie, Stéphane Dalle, Laurence Brugières, Brigitte Bressac-de Paillerets, Audrey Remenieras, Valérie Chaudru, Paola Ghiorzo, Hélène Blanché, Philippe Bahadoran, Fabienne Lesueur, Håkan Olsson, Bin Tean Teh, Philippe Vielh, Corine Bertolotto, Pascale Andry-Benzaquen, Thomas Strub, Florence Demenais, Vincent Molinié, Mahaut de Lichy, Susana Puig, Karine Bille, Sophie Gad, Annick Rossi, Mark Lathrop, Nicolas Dupin, Irwin Davidson, Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), and Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
0301 basic medicine ,Mutation ,Multidisciplinary ,Melanoma ,Carcinoma ,SUMO protein ,Cancer ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,Biology ,medicine.disease_cause ,medicine.disease ,Microphthalmia-associated transcription factor ,3. Good health ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Germline mutation ,medicine ,Cancer research ,Epigenetics ,030217 neurology & neurosurgery ,ComputingMilieux_MISCELLANEOUS - Abstract
Nature 480, 94–98 (2011); doi:10.1038/nature10539 In this Letter, one image was mistakenly duplicated during preparation of the artwork. In the original Fig. 3d, the left image illustrating migration of RCC4 cells transduced with empty adenovirus (EV) at 24 h is a duplicate of the middle image showing migration of RCC4 cells transduced with an adenovirus encoding Mi-WT.
- Published
- 2016
20. Polarization Observables in eta and pi Production Using a Polarized Target with the Crystal Ball/TAPS at MAMI
- Author
-
Thomas Strub, Lilian Witthauer, B. Krusche, M. Dieterle, Natalie K. Walford, and Pennington, M. R.
- Subjects
Nuclear physics ,Physics ,Particle physics ,Photon ,Meson ,Proton ,Isospin ,Nuclear Theory ,Neutron ,Nuclear Experiment ,Nucleon ,Pseudoscalar meson ,Crystal Ball - Abstract
Recent experiments using the Crystal Ball/TAPS setup at the MAMI accelerator in Mainz, Germany, continue to study the properties and the excitation spectrum of the nucleon with meson photoproduction. Electromagnetic excitations of the proton and neutron are essential for understanding their isospin decomposition. The electromagnetic coupling of photons to protons is different than that to neutrons in certain states. Hence, a complete partial wave analysis (PWA) can assist in yielding more information about any reaction, but requires the determination of polarization observables. Polarization observables play a crucial role as they are essential in disentangling the contributing resonant and non-resonant amplitudes, whereas cross section data alone is not sufficient for separating broad overlapping resonances. Preliminary results of polarization observables of η, single, and double π production off a polarized neutron (dButanol) target will be shown with comparison to predictions of recent multipole analyses. These results will greatly increase the world database on pseudoscalar meson production on neutrons.
- Published
- 2016
- Full Text
- View/download PDF
21. Chromatin-Remodelling Complex NURF Is Essential for Differentiation of Adult Melanocyte Stem Cells
- Author
-
Madeleine Le Coz, Irwin Davidson, Lionel Larue, Thomas Strub, Sebastien Coassolo, Dana Koludrovic, Gabrielle Mengus, Céline Keime, Patrick Laurette, Department of Functional Genomics and Cancer [Illkirch], Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), The Beatson Institute for Cancer Research, University of Glasgow, Department of Oncological Sciences [New York, NY, États-Unis], Icahn School of Medicine at Mount Sinai [New York] (MSSM), Signalisation normale et pathologique de l'embryon aux thérapies innovantes des cancers, Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Équipe labellisée Ligue Contre le Cancer [Orsay], Ligue Nationale Contre le Cancer (LNCC), Équipe labellisée Ligue Contre le Cancer [Strasbourg], This work was supported by grants from the CNRS, the INSERM, the Fondation ARC, the Ligue Nationale et Départementale contre le Cancer (Régions Alsace et Oise), the Institut National du Cancer (INCa) PAIR melanoma (MELA13-002), Cancéropole IdF, the ANR-10-LABX-0030-INRT French state fund through the ANR under the programme Investissements d’Avenir labelled ANR-10-IDEX-0002-02 and the Labex CelTisPhyBio (ANR-11-LBX-0038) under ANR-10-IDEX-0001-02. ID and LL are ‘équipe labellisées’ of the Ligue Nationale contre le Cancer., ANR-10-IDEX-0002,UNISTRA,Par-delà les frontières, l'Université de Strasbourg(2010), ANR-10-IDEX-0001,PSL,Paris Sciences et Lettres(2010), Bodescot, Myriam, Initiative d'excellence - Par-delà les frontières, l'Université de Strasbourg - - UNISTRA2010 - ANR-10-IDEX-0002 - IDEX - VALID, and Initiative d'excellence - Paris Sciences et Lettres - - PSL2010 - ANR-10-IDEX-0001 - IDEX - VALID
- Subjects
Cancer Research ,lcsh:QH426-470 ,Somatic cell ,Cellular differentiation ,Population ,Nerve Tissue Proteins ,Melanocyte ,Biology ,Mice ,03 medical and health sciences ,0302 clinical medicine ,[SDV.BBM] Life Sciences [q-bio]/Biochemistry, Molecular Biology ,Genetics ,medicine ,Animals ,[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology ,education ,Melanoma ,Molecular Biology ,Genetics (clinical) ,Ecology, Evolution, Behavior and Systematics ,030304 developmental biology ,Microphthalmia-Associated Transcription Factor ,0303 health sciences ,education.field_of_study ,integumentary system ,Cell Cycle ,Mesenchymal stem cell ,Gene Expression Regulation, Developmental ,Antigens, Nuclear ,Cell Differentiation ,Mesenchymal Stem Cells ,Chromatin Assembly and Disassembly ,Microphthalmia-associated transcription factor ,Cell biology ,Chromatin ,lcsh:Genetics ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Immunology ,Melanocytes ,Stem cell ,Hair Follicle ,Cell Division ,Transcription Factors ,Research Article - Abstract
MIcrophthalmia-associated Transcription Factor (MITF) regulates melanocyte and melanoma physiology. We show that MITF associates the NURF chromatin-remodelling factor in melanoma cells. ShRNA-mediated silencing of the NURF subunit BPTF revealed its essential role in several melanoma cell lines and in untransformed melanocytes in vitro. Comparative RNA-seq shows that MITF and BPTF co-regulate overlapping gene expression programs in cell lines in vitro. Somatic and specific inactivation of Bptf in developing murine melanoblasts in vivo shows that Bptf regulates their proliferation, migration and morphology. Once born, Bptf-mutant mice display premature greying where the second post-natal coat is white. This second coat is normally pigmented by differentiated melanocytes derived from the adult melanocyte stem cell (MSC) population that is stimulated to proliferate and differentiate at anagen. An MSC population is established and maintained throughout the life of the Bptf-mutant mice, but these MSCs are abnormal and at anagen, give rise to reduced numbers of transient amplifying cells (TACs) that do not express melanocyte markers and fail to differentiate into mature melanin producing melanocytes. MSCs display a transcriptionally repressed chromatin state and Bptf is essential for reactivation of the melanocyte gene expression program at anagen, the subsequent normal proliferation of TACs and their differentiation into mature melanocytes., Author Summary The melanocytes pigmenting the coat of adult mice derive from the melanocyte stem cell population residing in the permanent bulge area of the hair follicle. At each angen phase, melanocyte stem cells are stimulated to generate proliferative transient amplifying cells that migrate to the bulb of the follicle where they differentiate into mature melanin producing melanocytes, a processes involving MIcrophthalmia-associated Transcription Factor (MITF) the master regulator of the melanocyte lineage. We show that MITF associates with the NURF chromatin-remodelling factor in melanoma cells. NURF acts downstream of MITF in melanocytes and melanoma cells co-regulating gene expression in vitro. In vivo, mice lacking the NURF subunit Bptf in the melanocyte lineage show premature greying as they are unable to generate mature melanocytes from the adult stem cell population. We find that the melanocyte stem cells from these animals are abnormal and that once they are stimulated at anagen, Bptf is required to ensure the expression of melanocyte markers and their differentiation into mature adult melanocytes. Chromatin remodelling by NURF therefore appears to be essential for the transition of the transcriptionally quiescent stem cell to the differentiated state.
- Published
- 2015
22. Histone variant H2A.Z.2 mediates proliferation and drug sensitivity of malignant melanoma
- Author
-
Chiara Vardabasso, Thomas Strub, Eva C. Keilhauer, Chi-Yeh Chung, David Valle-Garcia, Jonathan Yao, Matthias Mann, Amit Verma, Emily Bernstein, Eva Hernando, Sandra B. Hake, Tobias Straub, Sebastian Pünzeler, Alexandre Gaspar-Maia, Miguel F. Segura, Taniya Panda, Barbara Fontanals-Cirera, Joanna Dong, Dan Hasson, and Rajendra Singh
- Subjects
Transcriptional Activation ,animal structures ,Biology ,Protein Serine-Threonine Kinases ,Article ,Metastasis ,Histones ,RNA interference ,Cell Line, Tumor ,medicine ,E2F1 ,Humans ,RNA, Small Interfering ,E2F ,Molecular Biology ,Melanoma ,Cell Proliferation ,Base Sequence ,Sequence Analysis, RNA ,Cell Biology ,Cell cycle ,medicine.disease ,Chromatin ,Histone ,Drug Resistance, Neoplasm ,embryonic structures ,S Phase Cell Cycle Checkpoints ,Cancer research ,biology.protein ,Melanocytes ,RNA Interference ,E2F1 Transcription Factor ,HeLa Cells ,Transcription Factors - Abstract
Histone variants are emerging as key regulatory molecules in cancer. We report a unique role for the H2A.Z isoform H2A.Z.2 as a driver of malignant melanoma. H2A.Z.2 is highly expressed in metastatic melanoma, correlates with decreased patient survival, and is required for cellular proliferation. Our integrated genomic analyses reveal that H2A.Z.2 controls the transcriptional output of E2F target genes in melanoma cells. These genes are highly expressed and display a distinct signature of H2A.Z occupancy. We identify BRD2 as an H2A.Z-interacting protein, levels of which are also elevated in melanoma. We further demonstrate that H2A.Z.2-regulated genes are bound by BRD2 and E2F1 in an H2A.Z.2-dependent manner. Importantly, H2A.Z.2 deficiency sensitizes melanoma cells to chemotherapy and targeted therapies. Collectively, our findings implicate H2A.Z.2 as a mediator of cell proliferation and drug sensitivity in malignant melanoma, holding translational potential for novel therapeutic strategies.
- Published
- 2015
23. Author response: Transcription factor MITF and remodeller BRG1 define chromatin organisation at regulatory elements in melanoma cells
- Author
-
Stein Aerts, Robert A. Cornell, Patrick Laurette, Hana Imrichova, Irwin Davidson, Dana Koludrovic, Gabrielle Mengus, Thomas Strub, Céline Keime, Robert Siddaway, Stéphanie Le Gras, Eric Van Otterloo, and Hannah Seberg
- Subjects
Melanoma ,medicine ,Biology ,Microphthalmia-associated transcription factor ,medicine.disease ,Transcription factor ,Chromatin organisation ,Cell biology - Published
- 2015
24. BRCA1 is a new MITF target gene
- Author
-
Corine Bertolotto, Laurent Beuret, Thomas Strub, Mickaël Ohanna, Robert Ballotti, Maryline Allegra, and Irwin Davidson
- Subjects
0303 health sciences ,03 medical and health sciences ,0302 clinical medicine ,Oncology ,030220 oncology & carcinogenesis ,Dermatology ,Target gene ,Biology ,Microphthalmia-associated transcription factor ,General Biochemistry, Genetics and Molecular Biology ,030304 developmental biology ,Cell biology - Published
- 2011
25. Polarization Observables T and F in single π0- and η-Photoproduction off quasi-free Nucleons
- Author
-
Thomas Strub
- Subjects
Quantum chromodynamics ,Physics ,Particle physics ,Photon ,Meson ,QC1-999 ,Nuclear Theory ,Nuclear physics ,Isospin ,Neutron ,High Energy Physics::Experiment ,Nucleon ,Nuclear Experiment ,Microtron ,Crystal Ball - Abstract
Meson photoproduction has developed into a powerful tool to study the nu- cleon excitation spectrum and test effective quark models which operate in the non- perturbative regime of QCD. An insight into the J P configurations and isospin decom- positions of the contributing resonances is gained by measuring a minimal set of polar- ization observables on both the proton and the neutron. Single π 0 - and η-photoproduction off a transversally polarized d-butanol target has been measured with circularly polarized bremsstrahlung photons generated by the MAMI-C electron microtron. With the nearly 4π acceptance of the combined Crystal Ball/TAPS setup the double polarization observable F and the target asymmetry T can be extracted for the first time for polarized, quasi-free neutrons over a wide energy and angular range.
- Published
- 2014
26. A POU3F2-MITF-SHC4 Axis in Phenotype Switching of Melanoma Cells
- Author
-
Thomas Strub, Dana Koludrovic, Irwin Davidson, and Dominique Kobi
- Subjects
Retinal pigment epithelium ,medicine.anatomical_structure ,Melanoblast ,Melanoma ,Cancer research ,medicine ,Neural crest ,Biology ,Melanocyte ,Microphthalmia-associated transcription factor ,medicine.disease ,Phenotype ,Embryonic stem cell - Abstract
Malignant melanoma is one of the most aggressive human cancers. Metastatic melanoma is highly resistant to genotoxic radiotherapy and chemotherapeutic treatments and patients have a median survival of under a year from diagnosis. As primary melanoma tumours can metastasise very early in tumour development (Chin et al., 2006), rapid diagnosis and curative surgery remain the best hopes for control of the disease. Early surgery that removes radial growth phase tumours that have not yet initiated vertical growth phase can be very effective and prevent further development. However, once the primary tumour has begun to invade the local epidermal and dermal environment treatment becomes much more complicated Why melanoma has such a high propensity to invade and metastasize is not well understood, but may be related to the developmental characteristics of the melanocyte lineage. Melanocytes derive from pluripotent neural crest cells as non-pigmented melanoblasts (Dupin et al., 2007; Dupin et al., 2006; Thomas and Erickson, 2008). During embryogenesis melanoblasts migrate via the dorso-lateral pathway to populate the basal layer of the epidermis and hair follicles, as well as a number of other sites including the inner ear and the heart (Yajima and Larue, 2008). The ability of transformed melanoma cells to rapidly invade and migrate away from the primary tumour perhaps reflects an inherent characteristic inherited from their embryonic state. Neural crest-derived cells are specified as melanoblasts by expression of MIcrophthalmiaassociated Transcription Factor (MITF), a basic helix-loop-helix transcription factor belonging to the MYC superfamily (Goding, 2000a; Goding, 2000b; Hemesath et al., 1994). The MITF locus encodes multiple isoforms generated by alternate splicing and use of internal promoters (Steingrimsson, 2008). The MITF-M isoform (hereafter designated simply as MITF) is produced specifically in the melanocyte lineage from an intronic promoter. MITF is required for melanoblast survival and differentiation of the retinal pigment epithelium (RPE) (Hou and Pavan, 2008; McGill et al., 2002). Consequently, MITF-null mice exhibit a white coat colour due to the loss of the melanocyte lineage and a small (microphthalmic) eye phenotype due to loss of the RPE (Hodgkinson et al., 1993; Hughes et al., 1993; Moore, 1995; Steingrimsson et al., 1994). In humans, mutation of the MITF gene is responsible for Waardenburg syndrome type 2 (WS2) ((Tassabehji et al., 1994), a syndrome characterised by pigmentary defects and hearing loss highlighting the important role of the
- Published
- 2011
27. Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma
- Author
-
Caroline Bonet, Céline Keime, Mireille Cormont, Thomas Strub, Sandy Giuliano, Robert Ballotti, Irwin Davidson, D Kobi, Corine Bertolotto, S Le Gras, Tao Ye, Institut de génétique et biologie moléculaire et cellulaire (IGBMC), Université Louis Pasteur - Strasbourg I-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre méditérannéen de médecine moléculaire (C3M), Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Nice Sophia Antipolis (1965 - 2019) (UNS), and BERTOLOTTO-BALLOTTI, BERTOLOTTO-BALLOTTI
- Subjects
Cancer Research ,senescence ,DNA damage ,DNA repair ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,Biology ,03 medical and health sciences ,0302 clinical medicine ,[SDV.CAN] Life Sciences [q-bio]/Cancer ,Genetics ,medicine ,cancer ,metastasis ,Molecular Biology ,Transcription factor ,Mitosis ,030304 developmental biology ,0303 health sciences ,integumentary system ,Melanoma ,DNA replication ,Cell cycle ,medicine.disease ,Microphthalmia-associated transcription factor ,3. Good health ,body regions ,030220 oncology & carcinogenesis ,Cancer research ,Chromatin immunoprecipitation - Abstract
Comment inCommentary. A picture of Mitf in melanoma immortality. [Oncogene. 2011]; International audience; Malignant melanoma is an aggressive cancer known for its notorious resistance to most current therapies. The basic helix-loop-helix microphthalmia transcription factor (MITF) is the master regulator determining the identity and properties of the melanocyte lineage, and is regarded as a lineage-specific 'oncogene' that has a critical role in the pathogenesis of melanoma. MITF promotes melanoma cell proliferation, whereas sustained supression of MITF expression leads to senescence. By combining chromatin immunoprecipitation coupled to high throughput sequencing (ChIP-seq) and RNA sequencing analyses, we show that MITF directly regulates a set of genes required for DNA replication, repair and mitosis. Our results reveal how loss of MITF regulates mitotic fidelity, and through defective replication and repair induces DNA damage, ultimately ending in cellular senescence. These findings reveal a lineage-specific control of DNA replication and mitosis by MITF, providing new avenues for therapeutic intervention in melanoma. The identification of MITF-binding sites and gene-regulatory networks establish a framework for understanding oncogenic basic helix-loop-helix factors such as N-myc or TFE3 in other cancers.
- Published
- 2011
28. BRCA1 is a new MITF target gene
- Author
-
Laurent, Beuret, Mickael, Ohanna, Thomas, Strub, Maryline, Allegra, Irwin, Davidson, Corine, Bertolotto, and Robert, Ballotti
- Subjects
Microphthalmia-Associated Transcription Factor ,Skin Neoplasms ,BRCA1 Protein ,Tumor Suppressor Proteins ,Cell Cycle Proteins ,Ataxia Telangiectasia Mutated Proteins ,Protein Serine-Threonine Kinases ,Transfection ,DNA-Binding Proteins ,Histones ,Mice ,Cell Line, Tumor ,Checkpoint Kinase 1 ,Animals ,Humans ,Gene Silencing ,Phosphorylation ,RNA, Small Interfering ,Melanoma ,Protein Kinases - Published
- 2011
29. Abstract A12: Histone variant H2A.Z.2 mediates proliferation and drug sensitivity of malignant melanoma
- Author
-
Eva Hernando, Amit Verma, Miguel F. Segura, Matthias Mann, Taniya Panda, Chi-Yeh Chung, Emily Bernstein, Tobias Straub, Sebastian Pünzeler, Chiara Vardabasso, Alexandre Gaspar-Maia, Eva C. Keilhauer, Thomas Strub, David Valle-Garcia, Dan Hasson, and Sandra B. Hake
- Subjects
Cancer Research ,biology ,Melanoma ,Cancer ,medicine.disease ,Bromodomain ,Metastasis ,Histone H4 ,Histone ,Oncology ,Immunology ,medicine ,Cancer research ,biology.protein ,Epigenetics ,Skin cancer - Abstract
Malignant melanoma is the most lethal form of skin cancer with rising incidence. Once metastasis occurs, patients have a dismal prognosis, largely due to limited systemic treatment with chemotherapy and resistance to targeted therapies. Thus, effective therapies with long-term responses are currently lacking. Although much effort has focused on characterizing and targeting the genetic alterations in melanoma, the identification of epigenetic players remains poorly understood. Chromatin dynamics have recently been shown to exert a critical function in a number of cancers, including melanoma, and emerging evidence points towards a role of histone variants as key regulatory molecules in cancer. H2A.Z is a highly conserved H2A variant, harboring two different isoforms in vertebrates, H2A.Z.1 and H2A.Z.2. High levels of H2A.Z promote cell proliferation in breast, prostate and bladder cancers, however studies so far have focused primarily on H2A.Z.1 or did not clearly distinguish between the two isoforms. Here, we report a role for the unappreciated isoform H2A.Z.2 as a mediator of cell proliferation and drug sensitivity in malignant melanoma. To our knowledge, this is the first evidence to implicate a distinct role for this H2A.Z isoform in any tumor type. While both H2A.Z.1 and H2A.Z.2 are highly expressed in metastatic melanoma and correlate with decreased patient survival, only H2A.Z.2 deficiency results in impaired cellular proliferation, which occurs through a G1 to S arrest. Integrated gene expression and ChIP-seq analyses revealed that H2A.Z.2 positively regulates E2F target genes, which are highly expressed and acquire a distinct H2A.Z occupancy signature over the promoter and gene body in metastatic cells. We further identified the BET (bromodomain and extraterminal domain) family member BRD2 as an H2A.Z-interacting protein in melanoma cells, and our data suggest that H2A.Z.2 exerts its oncogenic function by maintaining the global levels of BRD2 and histone H4 acetylation. Furthermore, H2A.Z.2 depletion sensitizes melanoma cells to targeted therapies and chemotherapy. Collectively, our findings implicate H2A.Z.2 as a driver of melanoma pathogenesis. Owing to the fact that histone modification is a reversible process, H2A.Z.2 and BRD2 hold translational potential for novel therapeutic strategies. Citation Format: Chiara Vardabasso, Alexandre Gaspar-Maia, Sebastian Punzeler, David Valle-Garcia, Dan Hasson, Tobias Straub, Eva C. Keilhauer, Thomas Strub, Taniya Panda, Miguel F. Segura, Chi-Yeh Chung, Amit K. Verma, Matthias Mann, Eva Hernando, Sandra B. Hake, Emily Bernstein. Histone variant H2A.Z.2 mediates proliferation and drug sensitivity of malignant melanoma. [abstract]. In: Proceedings of the AACR Special Conference on Advances in Melanoma: From Biology to Therapy; Sep 20-23, 2014; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(14 Suppl):Abstract nr A12.
- Published
- 2015
30. Tuning Transcription Factor Availability through Acetylation-Mediated Genomic Redistribution
- Author
-
Xin Lu, Min Lu, Thomas Strub, Richard Lisle, Davide Mazza, Eiríkur Steingrímsson, Panagis Filippakopoulos, Eda Suer, Benjamin Thomas, Robert Siddaway, Pakavarin Louphrasitthiphol, Benjamin Schuster-Böckler, Jean-Philippe Lambert, Alessia Loffreda, Vivian Pogenberg, Hans Friedrichsen, Mark R. Middleton, Zhiqiang Zeng, E. Elizabeth Patton, Colin R. Goding, Irwin Davidson, Matthias Wilmanns, Rasmus Freter, Alexander Schepsky, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA), Læknadeild (HÍ), Faculty of Medicine (UI), Heilbrigðisvísindasvið (HÍ), School of Health Sciences (UI), Háskóli Íslands, University of Iceland, Louphrasitthiphol, P, Siddaway, R, Loffreda, A, Pogenberg, V, Friedrichsen, H, Schepsky, A, Zeng, Zq, Lu, M, Strub, T, Freter, R, Lisle, R, Suer, E, Thomas, B, Schuster-Bockler, B, Filippakopoulos, P, Middleton, M, Lu, X, Patton, Ee, Davidson, I, Lambert, Jp, Wilmanns, M, Steingrimsson, E, Mazza, D, and Goding, Cr
- Subjects
MAPK/ERK pathway ,Male ,Skin Neoplasms ,melanocyte ,Sortuæxli ,[SDV]Life Sciences [q-bio] ,medicine.disease_cause ,DNA-binding affinity ,Mice ,0302 clinical medicine ,Promoter Regions, Genetic ,Melanoma ,Conserved Sequence ,Zebrafish ,transcription factor ,ComputingMilieux_MISCELLANEOUS ,0303 health sciences ,Genome ,Acetylation ,Microphthalmia-associated transcription factor ,3. Good health ,Cell biology ,Gene Expression Regulation, Neoplastic ,Enhancer Elements, Genetic ,Heterografts ,Melanocytes ,Female ,Protein Binding ,Mice, Nude ,E-box ,Biology ,Article ,03 medical and health sciences ,bHLH-LZ ,Melanocyte ,Cell Line, Tumor ,medicine ,melanoma ,Animals ,Humans ,Protein Interaction Domains and Motifs ,Amino Acid Sequence ,Binding site ,Nucleotide Motifs ,Protein kinase A ,Molecular Biology ,Transcription factor ,030304 developmental biology ,acetylation ,Microphthalmia-Associated Transcription Factor ,MITF ,Binding Sites ,Sequence Homology, Amino Acid ,Cell Biology ,DNA-rannsóknir ,Carcinogenesis ,Protein Processing, Post-Translational ,Sequence Alignment ,030217 neurology & neurosurgery - Abstract
Publisher's version (útgefin grein), It is widely assumed that decreasing transcription factor DNA-binding affinity reduces transcription initiation by diminishing occupancy of sequence-specific regulatory elements. However, in vivo transcription factors find their binding sites while confronted with a large excess of low-affinity degenerate motifs. Here, using the melanoma lineage survival oncogene MITF as a model, we show that low-affinity binding sites act as a competitive reservoir in vivo from which transcription factors are released by mitogen-activated protein kinase (MAPK)-stimulated acetylation to promote increased occupancy of their regulatory elements. Consequently, a low-DNA-binding-affinity acetylation-mimetic MITF mutation supports melanocyte development and drives tumorigenesis, whereas a high-affinity non-acetylatable mutant does not. The results reveal a paradoxical acetylation-mediated molecular clutch that tunes transcription factor availability via genome-wide redistribution and couples BRAF to tumorigenesis. Our results further suggest that p300/CREB-binding protein-mediated transcription factor acetylation may represent a common mechanism to control transcription factor availability., The Piggybac vectors were provided by Kazuhiro Murakami (RIKEN, Kobe, Japan). This work was funded by the Ludwig Institute for Cancer Research (C.R.G., R.F., B.S.-B., E. Suer, and X.L. ), Cancer Research UK (CRUK) grant number C38302/A12981 , through a CRUK Oxford Centre Prize DPhil Studentship (HF), the Medical Research Council (R.S., Z.Z., P.F.; MR/N010051/1 and E.E.P.; MC_UU_00007/9 ), L’Oreal-Melanoma Research Alliance 401181 (E.E.P.), the Harry J. Lloyd Trust (R.S.), the Wellcome Trust (P.F. and A.S.), the Postdoc Fund of the University of Iceland (A.S.), the Oxford Biomedical Research Centre (R.L.), the Research Fund of Iceland (E.S.), a European Research Consolidator Award ( ZF-MEL-CHEMBIO 648489 ) (E.E.P.), the CNRS , INSERM , the Ligue Nationale Contre le Cancer , the Institut National du Cancer ( INCa ), the ANR-10-LABX-0030-INRT French state fund (I.D.), and a Junior 1 salary award from the Fonds de Recherche du Québec-Santé ( FRQ-S ). This work was also funded by operating grants from the Cancer Research Society (J.-P.L.), the Fondazione Cariplo (A.L. and D.M.; 2014-1157 ), and the Italian Cancer Research Association ( AIRC ; IG2018- 21897 ; D.M.). I.D. is an “équipe labellisée” of the Ligue Nationale Contre le Cancer .
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.